Comments on: Chronology of Prasugrel Controversy

By: Lilly reports modest sales figures for Effient (prasugrel) « CardioBrief

Lilly reports modest sales figures for Effient (prasugrel) « CardioBrief — Thu, 28 Jan 2010 17:33:43 +0000

[...] Click here for a complete chronology of the prasugrel controversy. [...]

By: Medco launches 14,000 patient head-to-head observational comparison of clopidogrel and prasugrel « CardioBrief

Tue, 20 Oct 2009 16:17:31 +0000

[...] Click here for a complete chronology of the prasugrel controversy. [...]

By: FDA posts full drug approval package for prasugrel « CardioBrief

FDA posts full drug approval package for prasugrel « CardioBrief — Mon, 05 Oct 2009 17:35:33 +0000

[...] Click here for a complete chronology of the prasugrel controversy. [...]

By: Editor insists prasugrel ghostwriter go public « CardioBrief

Editor insists prasugrel ghostwriter go public « CardioBrief — Fri, 11 Sep 2009 16:27:44 +0000

[...] You can also read our prasugrel chronology. [...]

By: FDA official reviews his own prasugrel review in NEJM « CardioBrief

FDA official reviews his own prasugrel review in NEJM « CardioBrief — Wed, 02 Sep 2009 21:02:56 +0000

[...] Click here for a complete chronology of the prasugrel controversy. [...]

By: FDA official on prasugrel approval: “This has not been a well managed review process.” « CardioBrief

Tue, 11 Aug 2009 18:34:04 +0000

[...] Chronology of Prasugrel Controversy [...]

By: FDA approves prasugrel! « CardioBrief

FDA approves prasugrel! « CardioBrief — Fri, 10 Jul 2009 20:24:14 +0000

[...] Chronology of Prasugrel Controversy [...]

By: FDA official defends integrity of prasugrel review « CardioBrief

FDA official defends integrity of prasugrel review « CardioBrief — Fri, 19 Jun 2009 15:35:14 +0000

[...] Chronology of Prasugrel Controversy [...]

By: What do FDA insiders really think of prasugrel? « CardioBrief

What do FDA insiders really think of prasugrel? « CardioBrief — Fri, 12 Jun 2009 16:23:04 +0000

[...] What do FDA insiders really think of prasugrel? Posted on June 12, 2009 by Larry Husten The benefits of prasugrel in TRITON-TIMI 38 were greatly exaggerated by the “massive inclusion of ‘MIs” unreported by the trial investigators,” according to an editorial in Cardiology by Victor Serebruany. Serebruany’s severe criticism of prasugrel and TRITON will come as no surprise to CardioBrief readers. (See our prasugrel chronology for a detailed history of the controversy). [...]

By: UK’s NICE favors restricted approval for prasugrel « CardioBrief

UK’s NICE favors restricted approval for prasugrel « CardioBrief — Tue, 09 Jun 2009 14:14:55 +0000

[...] Here is a CardioBrief chronology of the prasugrel controversy. [...]